Skip to content

Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies

Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00958802
Enrollment
6
Registered
2009-08-13
Start date
2009-05-31
Completion date
2009-09-30
Last updated
2010-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microtia

Keywords

tissue engineering

Brief summary

Platelet-rich plasma (PRP) has mixed growth factors such as TGF-ß1 and TGF-ß2, vascular epithelial growth factor (VEGF), platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF). These growth factors appear to play an important role in wound healing and are assumed as promoters of tissue regeneration. Moreover, PRP was used as injectable scaffold seeded with chondrocytes to regenerate cartilage. In their previous study, the investigators concluded that growth factors in PRP can effectively react as a growth factor cocktail to induce human nucleus pulposus proliferation and differentiation, and also promote tissue-engineered nucleus pulposus formation. The investigators also have a hypothesis that PRP can promote tissue-engineered microtia auricular cartilage formation. TGF- ß1 exists in the highest concentration and is more important among all of the growth factors released from PRP. So TGF- ß1 can be used as the core ingredient and the indicator for applying PRP in these studies. The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.

Interventions

PRP was extracted from total blood and TGF-b1 was used as indicator

OTHERChondrocyte culture with FBS medium

Microtia chondrocyte culture with FBS medium only

Sponsors

Taipei Medical University WanFang Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* microtia patient

Exclusion criteria

* non microtia patient

Design outcomes

Primary

MeasureTime frame
The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.4 weeks

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026